Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H BLUM

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reports|March 1, 1978
Maytansine: a phase I study of an ansa macrolide with antitumor activityR H Blum, T Kahlert
American Journal of Clinical Oncology|August 1, 1989
A phase III randomized trial of epirubicin versus 5-fluorouracil in metastatic rectal/sigmoid adenocarcinomaP Molinaro, F Lafleur, R H Blum
Cancer Treatment Reports|January 1, 1981
Future clinical investigations with anthracycline antibiotics in relation to daunorubicinF M Muggia, R H Blum, J C Wernz
Cancer Chemotherapy and Pharmacology|January 1, 1993
Efficacy of ifosfamide in combination with doxorubicin for the treatment of metastatic soft-tissue sarcoma. The Eastern Cooperative Oncology GroupR H Blum, J Edmonson, L Ryan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1984
Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologiesF M Muggia, R H Blum, J D Foreman
Cancer Treatment Reports|June 1, 1978
Serial studies of cardiac function in patients receiving adriamycinI C Henderson, L J Sloss, N Jaffe, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Phase I study of doxorubicin, ICRF-187 and granulocyte/macrophage-colony-stimulating factorC Walsh, R H Blum, R Oratz, et al.
Cancer Treatment Reports|December 1, 1978
Phase I and preliminary phase II study of neocarzinostatinT W Griffin, R L Comis, J J Lokich, et al.
Journal of Clinical Pharmacology|February 1, 1987
Management of cancer pain with oral controlled-release morphine sulfateS D Meed, P M Kleinman, T G Kantor, et al.
Cancer Treatment Reports|May 1, 1979
Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analogR H Blum, M B Garnick, M Israel, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reports|March 1, 1978
Maytansine: a phase I study of an ansa macrolide with antitumor activityR H Blum, T Kahlert
American Journal of Clinical Oncology|August 1, 1989
A phase III randomized trial of epirubicin versus 5-fluorouracil in metastatic rectal/sigmoid adenocarcinomaP Molinaro, F Lafleur, R H Blum
Cancer Treatment Reports|January 1, 1981
Future clinical investigations with anthracycline antibiotics in relation to daunorubicinF M Muggia, R H Blum, J C Wernz
Cancer Chemotherapy and Pharmacology|January 1, 1993
Efficacy of ifosfamide in combination with doxorubicin for the treatment of metastatic soft-tissue sarcoma. The Eastern Cooperative Oncology GroupR H Blum, J Edmonson, L Ryan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1984
Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologiesF M Muggia, R H Blum, J D Foreman
Cancer Treatment Reports|June 1, 1978
Serial studies of cardiac function in patients receiving adriamycinI C Henderson, L J Sloss, N Jaffe, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Phase I study of doxorubicin, ICRF-187 and granulocyte/macrophage-colony-stimulating factorC Walsh, R H Blum, R Oratz, et al.
Cancer Treatment Reports|December 1, 1978
Phase I and preliminary phase II study of neocarzinostatinT W Griffin, R L Comis, J J Lokich, et al.
Journal of Clinical Pharmacology|February 1, 1987
Management of cancer pain with oral controlled-release morphine sulfateS D Meed, P M Kleinman, T G Kantor, et al.
Cancer Treatment Reports|May 1, 1979
Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analogR H Blum, M B Garnick, M Israel, et al.
Pageof 5